Cyclin-Dependent Kinase 5 (CDK5) (Middle Region) Peptide
CDK5
Reactivity: Human, Rat
Host: Synthetic
BP, WB
-
- Target See all CDK5 products
- CDK5 (Cyclin-Dependent Kinase 5 (CDK5))
- Protein Region
- Middle Region
- Origin
- Human, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- EIVKSLLFQL LKGLGFCHSR NVLHRDLKPQ NLLINRNGEL KLADFGLARA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Cdk5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CDK5 (Cyclin-Dependent Kinase 5 (CDK5))
- Background
-
Serine/threonine kinase is involved in synaptic regulation and neuronal development, phosphorylates synaptic protein Pctaire1 and regulates acetylcholine receptor expression.
Alias Symbols: -
Protein Size: 292 - Molecular Weight
- 32 kDa
- Gene ID
- 140908
- NCBI Accession
- NM_080885, NP_543161
- UniProt
- Q03114
-
You are here:
